Diagnosis and treatment of adenovirus infection in immunocompromised patients
- 1 October 2013
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 11 (10) , 1017-1028
- https://doi.org/10.1586/14787210.2013.836964
Abstract
In immunocompromised patients, human adenovirus (HAdV) infections can cause life-threatening multiorgan disease. This review summarizes the incidence and risk factors of invasive human adenovirus infections in immunocompromised patients as well as the recently developed standards for diagnostic methods and strategies according to the predominant risk factors in adults and children. Recommendations for preemptive and therapeutic treatment strategies and the outcome in different risk groups are presented. Novel therapeutic approaches including CMX001, a new orally bioavailable lipid conjugate of cidofovir and the transfer of adenovirus-specific donor T cells in the context of allogeneic stem cell transplantation are discussed.Keywords
This publication has 160 references indexed in Scilit:
- Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machineryAntiviral Research, 2012
- Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised PatientsTransplantation and Cellular Therapy, 2011
- Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactiveVaccine, 2010
- Respiratory viruses, a common microbiological finding in neutropenic children with feverJournal of Clinical Virology, 2010
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal modelProceedings of the National Academy of Sciences, 2008
- Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infectionThe Journal of Experimental Medicine, 2008
- Genotype Prevalence and Risk Factors for Severe Clinical Adenovirus Infection, United States 2004-2006Clinical Infectious Diseases, 2007
- Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantationBritish Journal of Haematology, 2006
- Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2003